|
Science and Technology Roadmapping: implications for eHealthMark Boden and Olivier Da Costa,IPTSIssue: Recent S&T roadmapping studies have focused on the potential of various emerging information and communication technologies to help meet the challenges faced by European healthcare systems dealing with an ageing population, the enlargement of European Union and growing healthcare budget constraints. Roadmaps are an effective and intuitive way to present and analyse the causal and temporal relations in these roadmaps. IntroductionTechnology roadmapping is a widely used methodology, employed by individual companies, entire industries and public research institutes (Da Costa et al. 2003) as a way of bringing together various stakeholder perspectives so as to develop an overview of how a technological field, or an industry is likely to develop over a set future period. This approach can be applied to analysing the scientific and technological, economic, political and social dimensions of a wide range of fields, and the interactions between them. It is therefore highly appropriate to a complex area such as eHealth (see Box 1). Box 1. The IPTS-ESTO roadmapping exercise
In August 2002, the IPTS and the European Science and Technology Observatory (ESTO) launched a project aimed at developing science and technology roadmapping (S&TRM) as an input into policy making at European level. The project was underpinned by three main issues: Dimensions of the Challenges and Policy IssuesIncreasing demands on European healthcare systems are a consequence of the changing demographics1 and economic development of Europe. The effective delivery of healthcare represents a challenge to which a combination of emerging technological developments could respond. The HCTRM set out four key drivers of change emerging over the next decade to shape the future of healthcare delivery.
In the context of EU enlargement and rapid technological change, there is a clear danger of the 'health gap' between regions and social classes increasing Within this context, there is a clear danger of a widening of the 'health gap' between regions and social classes. A recent report delivered to the European Council (European Commission, DG Employment and Social Affairs 2003) examines the challenges faced by healthcare systems in the European Union and the need to ensure a good balance between three objectives:
The combination of the above drivers and policy challenges provided the context in which the HCTRM examined emerging technologies and AmI@Life the health application area. Box 2. Complementary Perspectives on the Development of eHealthThe HCTRM, was an issue-driven study in which eHealth was considered from a technological perspective. The basic methodology centred on a matrix-based framework in which to describe and analyse the current state of healthcare technologies (Footprint Matrix) and to articulate a vision of the future situation (Matrix 2020). The provision of customizable telecare which can be easily deployed and adapted in individuals' homes to meet their particular needs is a key goal The main goal is the provision of customizable telecare, which can be easily deployed and adapted in individuals' homes to meet their particular needs. This relies on a number of key enabling technologies, which include high-speed wireless communications, digital interfaces, database and data mining technologies, sensors and actuators. Specific applications will include passive devices to detect accidents and hazards; memory aids; lifestyle and physiological monitoring systems; specialized telephones and videoconferencing; speech recognition for data capture and computer command; and mobile devices to connect with computer systems during the patient care process. Telecare will be also integrated into assistive equipment, such as walking sticks, bath seats, grab rails, and wheelchairs, particularly in the context of the smart home. Health applications for AmI technologies have been found to be very demanding but also very promising, in terms of improving the process of care delivery and facilitating linkages between the different actors. However, although prototypes can be expected within the next 3-5 years, widespread use of most of these applications is not expected until 2010. Figure 1. AmI@Life Roadmap for health applications
Bringing together the implications of the two roadmaps, patients should benefit from improved quality in the prevention and treatment of illness and in aftercare and rehabilitation thanks to improved capabilities in the measurement, recording, and analysis of data and to the increasing availability of minimally invasive surgery and telecare. Improved measurement, recording, and analysis of data and increasing availability of minimally invasive surgery and telecare should enable patients to benefit from improved prevention and treatment of illness Healthcare professionals will benefit from easier access to patient-specific information and to general professional information. They will be able to match measurements and observations with recorded information about the user, even including data such as eating habits. Later on, when gene-based treatments become available, healthcare practitioners will be able to access the patients' genetic data. Given the current early state of development of pharmacogenomics, relevant integrated information systems are not likely to be available in all EU healthcare systems until 2020. Patients might one day also carry smart-cards containing such genetic data. Healthcare professionals will also be able to take advantage of ambient intelligence (AmI) based decision-support systems and support services in health management and administration Healthcare professionals will also be able to take advantage of AmI-based decision-support systems and support services in health management and administration. For instance, prototypes for the identification and authentication of medical personnel and patients should be available within the next two years, with wider introduction possible after 2007. Wider diffusion of health information and education systems, already feasible, will facilitate better informed encounters with patients and with other care professionals. Advanced applications using mobile communication are likely to become available after 2004. The availability, as early as 2005, of sensor technologies will underpin advances in alert and alarm systems and robotics. These will be further developed with the availability of micro actuators after 2006. Monitoring capabilities will be particularly enhanced by the development of ambient intelligence (AmI) technologies As a consequence, monitoring, which relies mainly on the combination of sensors monitoring vital functions and networking technologies, will particularly benefit from the development of AmI technologies. The first prototypes of AmI-based monitoring systems should appear in about five years while 'intelligent' and context sensitive monitoring systems are unlikely to be feasible before 2020, given the high degree of uncertainty surrounding the development of Artificial Intelligence. AmI-based prediction and diagnosis should progress from the measurement of predefined indicators to knowledge-based systems capable of diagnoses based on a range of indicators AmI-based prediction and diagnosis relies on data monitoring, and after 2007, should develop from the measurement of predefined indicators, such as blood sugar level and heart rate, to knowledge-based systems capable of diagnoses based on a range of indicators. Tele-consultation is already in use ( e.g. on ships), and will embrace AmI technologies as they become available. The need for visual communication between patients and healthcare professionals will be met by widespread availability of broadband networks. On the 2020 horizon, telecare and minimally invasive surgery should be widely used together. Ultimately all AmI-related functions in the health field are likely to tend towards convergence in a single system. The overall healthcare system will benefit from the optimization of resource use, scale economies, better use of public health information and a more highly-skilled workforce. There may also be major implications for the organization of care, with more delivery in the community and minimization of inappropriate admissions, long stays and readmission. There will be increased emphasis on chronic disease management and support for patient self-management. Possible areas for further research in the field include artificial intelligence tools for screening clinical data and alerting physicians; expert systems for decision support; and nanotechnology and its convergence with biotechnology. The future opportunities for industry include: construction of smart homes and retrofitting of the existing housing stock; production of sensors and sensor systems; compilation and maintenance of large, searchable databases. Policy ImplicationsThe provision of healthcare across Europe is becoming much more complex. The roles and responsibilities of the institutions, practitioners and even users are changing. The general trends which will influence policy considerations include:
The provision of healthcare is changing, with a blurring of the boundaries between private and public health care, greater emphasis on prevention, increased decentralization, etc. In particular, the implications of the development and diffusion of e-health for the three objectives defined by the European Council include:
The main drivers and factors influencing the diffusion of healthcare technologies, including eHealth, have been identified as: the cost of development and provision, research and development, availability of skills, organization of healthcare system, ethical concerns, cost of use and reimbursement. Most of these factors are healthcare provider, industry, system or policy related. Future deployment of eHealth is conditioned by an adequate understanding of the social context by the public authorities, healthcare providers and other stakeholders. Without appropriate government policies it is unlikely to occur (Barlow et al. 2003). Key areas for policy intervention include:
In the two roadmaps, examination of the key trajectories of scientific and technological development in their socio-economic context, with the contributions of expert knowledge and opinions, has identified and illuminated issues of concern for policy. The ability of the roadmaps to generate perspectives on policy implications demonstrates the potential value of the roadmapping approach in policy intelligence.
KeywordseHealth, delivery of healthcare, science and technology roadmapping, S&TRM, policy intelligence Notes1. Life expectancy at birth has increased by six years in the EU on average from 1970 to 1996 and is now between 75 years and 79 years in all Member States. 2. The global HCT & pharmaceutical market in 2001 globally was 600 billion US$, with HCT representing one third and pharmaceutical two-thirds (Eucomed). ReferencesAcknowledgementsWe are grateful to our roadmapping partners who contributed to the project. For HCTRM: Anette Braun (VDI), James Barlow (SPRU), Kristian Borch (RISØ), James Ryan (CIRCA), Niilo Saranummi (VTT), Hindrik Vondeling (SDU), Fernando Gil Alonso (European Commission, Employment and Social Affairs Directorate-General), David Rickerby (Advisory Cell for Science and Technology, JRC), Marianne Takki, (European Commission, Health and Consumer Protection Directorate-General), Mario Zappacosta (ex IPTS). For AmI@Life: Yves Punie from IPTS, Michael Friedewald from Fraunhofer-ISI, Pieter Ballon, Lucien Dantuma and Desiree Hoving from TNO STB. ContactsMark Boden, IPTS E-mail: Contact Form Olivier Da Costa, IPTS E-mail: Contact Form About the authors
|